Captopril in the treatment of hypertension in type I and type II diabetic patients.
Giovanni Gambaro, Francesco Filippo Morbiato, Elisa Cicerello, Del Turco M, L Sartori, Angela D’Angelo, Gaetano Crepaldi
Abstract
Giovanni Gambaro, Francesco Filippo Morbiato, Elisa Cicerello, Del Turco M, L Sartori, Angela D’Angelo, Gaetano Crepaldi
Abstract
Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.
Key concepts: Medicine, Captopril, Blood pressure, Internal medicine, Hemodynamics, Adverse effect, Endocrinology, Cardiology